A-148 Thromboelastography Utilization in a Community Hospital Setting

Abstract

Abstract Background Thromboelastography (TEG) applications have been gaining momentum in various clinical settings and service lines. However, the utilization of the technology varies among clinical establishments and requires additional assessment for TEG optimization among its user groups. Methods TEG (Haemonetics TEG6s) was applied in a community hospital based setting in SICU, OR and ED service lines to identify instrument prompted blood product support over a two month time period. Results Forty one measurement were obtained from twenty patients. SICU represented the majority of TEG use (78%) followed by OR (15%). Global TEG run assessments were completed on 27%, platelet mapping on 46%, and heparin assessment on 56% of samples. Global TEG recommendations included factor deficiency with suggested FFC or PCC use (12%) or no recommendations (10%). Platelet assessments recommended no product (19.5%), or ADP inhibition with platelet consideration if bleeding (14.6%). Heparin assessment indicated no treatment (44%) and above normal CK/R time with FFP or PCC if bleeding (10%). Conclusion TEG applications in various services suggested no need for blood product or factor application in the majority of platelet mapping and heparin assessments. Other assessments yielded about a half dozen suggestions from the instrument’s 150 suggestion options. TEG application appears to be easily implementable and suggests no treatment or a few repetitive treatment options for the majority of patients assessed thereby reducing onboarding educational and improving management requirements for select user groups.